Anders Tidblad

Anders Tidblad

Affiliated to Research
Visiting address: Bioclinicum J9:30, Akademiska stråket 1, 17164 Solna
Postal address: K6 Kvinnors och barns hälsa, K6 Barnendokrinologi Sävendahl, 171 77 Stockholm
Part of:

About me

  • Education
    PhD, Dept of Women’s and Children’s Health, Karolinska Institute

    Karolinska Institute’s Doctoral School for Clinicians in Epidemiology

    Medical School, Karolinska Institute

    BA (Fil. kand) in Political Science incl. courses in International Relations, History, Philosophy and Psychology, Stockholm University

Research

  • Recombinant Growth Hormone (GH) treatment has been in clinical use since 1985 and over 7000 children in Sweden have been treated since its introduction. It is well known that treatment with GH in childhood improves height, has several metabolic effects in body composition and seems to have a well-tolerated short-term safety profile. However, it is not known what long-term effects this treatment has on the risk of developing morbidity potentially associated with the physiological effects of GH. The aim of our project is to assess these risks both in the short- and long-term.

Articles

All other publications

Employments

  • Affiliated to Research, Department of Women's and Children's Health, Karolinska Institutet, 2022-2025

Degrees and Education

  • Degree Of Doctor Of Philosophy, Department of Women's and Children's Health, Karolinska Institutet, 2019
  • University Medical Degree, Karolinska Institutet, 2006

News from KI

Events from KI